Filing Details
- Accession Number:
- 0001209191-10-039277
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-21 13:00:00
- Reporting Period:
- 2010-07-19
- Filing Date:
- 2010-07-21
- Accepted Time:
- 2010-07-21 18:56:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1390478 | Rxi Pharmaceuticals Corp | RXII | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1460224 | Ramani Varanasi | C/O Rxi Pharmaceuticals Corporation 60 Prescott Street Worcester MA 01605 | Vp Business Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-07-19 | 5,000 | $2.05 | 5,558 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-07-19 | 5,600 | $2.04 | 11,158 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | A | Direct |
Footnotes
- The sale price reported in this Form 4 was between the range of $2.05 per share and $2.05432 per share. Full information regarding the number of shares sold at each seperate price will be provided to the Commission staff upon request.